3 Months, Open-Label, Parallel-Group Study of the Pharmacodynamics, Pharmacokinetics and Safety of TAP-144SR 1-Month Depot Gelatin-Free vs. Gelatin-Containing Formulation in Female Patients With Uterine Fibroids.
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2013
At a glance
- Drugs Leuprorelin (Primary)
- Indications Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Takeda Pharma
- 08 Nov 2008 New trial record.